Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis
American Journal of Respiratory Cell and Molecular Biology · 01.11.2023 · 69 (5) · 556-569
DOI: 10.1165/rcmb.2022-0315oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 01.11.2023. Verfasst von Justin Sui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, NAD. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by progressive lung scarring and remodeling. Although treatments exist that slow disease progression, IPF is irreversible, and there is no cure. Cellular senescence, a major hallmark of aging, has been implicated in IPF pathogenesis, and mitochondrial dysfunction is increasingly recognized as a driver of senescence. Adenine nucleotide translocases (ANTs) are abundant mitochondrial ATP–ADP transporters critical for regulating cell fate and maintaining mitochondrial function. We sought to determine how alterations in ANTs influence cellular senescence in pulmonary fibrosis. We found that SLC25A4 (solute carrier family 25 member 4) (ANT1) and SLC25A5 (ANT2) expression is reduced in the lungs of patients with IPF, particularly within alveolar type II (AT2) cells, by single-cell RNA sequencing and tissue staining. Loss of ANT1 by siRNA in lung epithelial cells resulted in increased senescence markers such as β-galactosidase and p21, with a reduction in the ratio of nicotinamide adenine dinucleotide to reduced nicotinamide adenine dinucleotide. Bleomycin-treated ANT1 knockdown cells also had increased senescence markers compared with bleomycin-treated control cells. Loss of ANT1 in AT2 cells resulted in a reduction in alveolar organoid growth, with an increase in p21 by staining. Global loss of ANT1 resulted in worse lung fibrosis and increased senescence in the bleomycin- and asbestos-induced mouse models of pulmonary fibrosis. In summary, loss of ANT1 contributes to IPF pathogenesis through mitochondrial dysfunction, increased senescence, and decreased regenerative capacity of AT2 cells, resulting in enhanced lung fibrosis. Modulation of ANTs presents a new therapeutic avenue that may alter cellular senescence pathways and limit pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
ORCID-Profile: Melanie Königshoff, Corrine R Kliment
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- National Heart, Lung, and Blood Institute
- Burroughs Wellcome Fund
- Parker Foundation
Zitieren
APA
Sui, J., Boatz, J. C., Shi, J., Hu, Q., Li, X., Zhang, Y., Königshoff, M., & Kliment, C. R. (2023). Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 69(5), 556-569. https://doi.org/10.1165/rcmb.2022-0315oc
Vancouver
Sui J, Boatz JC, Shi J, Hu Q, Li X, Zhang Y, et al. Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 2023;69(5):556-569. doi:10.1165/rcmb.2022-0315oc
BibTeX
@article{Sui2023,
author = {Sui, Justin and Boatz, Jennifer C and Shi, Jian and Hu, Qianjiang and Li, Xiaoyun and Zhang, Yingze and Königshoff, Melanie and Kliment, Corrine R},
title = {Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2023},
volume = {69},
number = {5},
pages = {556--569},
doi = {10.1165/rcmb.2022-0315oc}
}
EUVIMED